Patents by Inventor Chelsea G. Gordon

Chelsea G. Gordon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • D-amino acid derivative-modified peptidoglycan and methods of use thereof
    Patent number: 10016498
    Abstract: The present disclosure provides modified bacteria and modified peptidoglycan comprising modified D-amino acids; compositions comprising the modified bacteria or peptidoglycan; and methods of using the modified bacteria or peptidoglycan. The modified D-amino acids include a bioorthogonal functional group such as an azide, an alkyne or a norbornene group. Also provided are modified peptidoglycans conjugated to a molecule of interest via a linker.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: July 10, 2018
    Assignee: The Regents of the University of California
    Inventors: Carolyn R. Bertozzi, Mary Sloan Siegrist Palmore, John C. Jewett, Chelsea G. Gordon, Peyton Shieh
  • D-AMINO ACID DERIVATIVE-MODIFIED PEPTIDOGLYCAN AND METHODS OF USE THEREOF
    Publication number: 20180000929
    Abstract: The present disclosure provides modified bacteria and modified peptidoglycan comprising modified D-amino acids; compositions comprising the modified bacteria or peptidoglycan; and methods of using the modified bacteria or peptidoglycan. The modified D-amino acids include a bioorthogonal functional group such as an azide, an alkyne or a norbornene group. Also provided are modified peptidoglycans conjugated to a molecule of interest via a linker.
    Type: Application
    Filed: September 14, 2017
    Publication date: January 4, 2018
    Inventors: Carolyn R. Bertozzi, Mary Sloan Siegrist Palmore, John C. Jewett, Chelsea G. Gordon, Peyton Shieh
  • D-amino acid derivative-modified peptidoglycan and methods of use thereof
    Patent number: 9789180
    Abstract: The present disclosure provides modified bacteria and modified peptidoglycan comprising modified D-amino acids; compositions comprising the modified bacteria or peptidoglycan; and methods of using the modified bacteria or peptidoglycan. The modified D-amino acids include a bioorthogonal functional group such as an azide, an alkyne or a norbornene group. Also provided are modified peptidoglycans conjugated to a molecule of interest via a linker.
    Type: Grant
    Filed: March 31, 2016
    Date of Patent: October 17, 2017
    Assignee: The Regents of the University of California
    Inventors: Carolyn R. Bertozzi, Mary Sloan Siegrist Palmore, John C. Jewett, Chelsea G. Gordon, Peyton Shieh
  • D-AMINO ACID DERIVATIVE-MODIFIED PEPTIDOGLYCAN AND METHODS OF USE THEREOF
    Publication number: 20170021013
    Abstract: The present disclosure provides modified bacteria and modified peptidoglycan comprising modified D-amino acids; compositions comprising the modified bacteria or peptidoglycan; and methods of using the modified bacteria or peptidoglycan. The modified D-amino acids include a bioorthogonal functional group such as an azide, an alkyne or a norbornene group. Also provided are modified peptidoglycans conjugated to a molecule of interest via a linker.
    Type: Application
    Filed: March 31, 2016
    Publication date: January 26, 2017
    Inventors: Carolyn R. Bertozzi, Mary Sloan Siegrist Palmore, John C. Jewett, Chelsea G. Gordon, Peyton Shieh
  • D-amino acid derivative-modified peptidoglycan and methods of use thereof
    Patent number: 9303068
    Abstract: The present disclosure provides modified bacteria and modified peptidoglycan comprising modified D-amino acids; compositions comprising the modified bacteria or peptidoglycan; and methods of using the modified bacteria or peptidoglycan. The modified D-amino acids include a bioorthogonal functional group such as an azide, an alkyne or a norbornene group. Also provided are modified peptidoglycans conjugated to a molecule of interest via a linker.
    Type: Grant
    Filed: November 27, 2013
    Date of Patent: April 5, 2016
    Assignee: The Regents of the University of California
    Inventors: Carolyn R. Bertozzi, Mary Sloan Siegrist Palmore, John C. Jewett, Chelsea G. Gordon, Peyton Shieh
  • D-Amino Acid Derivative-Modified Peptidoglycan and Methods of Use Thereof
    Publication number: 20140170183
    Abstract: The present disclosure provides modified bacteria and modified peptidoglycan comprising modified D-amino acids; compositions comprising the modified bacteria or peptidoglycan; and methods of using the modified bacteria or peptidoglycan. The modified D-amino acids include a bioorthogonal functional group such as an azide, an alkyne or a norbornene group. Also provided are modified peptidoglycans conjugated to a molecule of interest via a linker.
    Type: Application
    Filed: November 27, 2013
    Publication date: June 19, 2014
    Applicant: The Regents of the University of California
    Inventors: Carolyn R. Bertozzi, Mary Sloan Siegrist Palmore, John C. Jewett, Chelsea G. Gordon, Peyton Shieh
  • Compositions and methods for modification of biomolecules
    Patent number: 8703936
    Abstract: Provided are modified cycloalkyne compounds; and methods of use of such compounds in modifying biomolecules. Embodiments include a cycloaddition reaction that can be carried out under physiological conditions. The cycloaddition reaction involves reacting a modified cycloalkyne with an azide moiety on a target biomolecule, generating a covalently modified biomolecule. The selectivity of the reaction and its compatibility with aqueous environments provide for its application in vivo and in vitro.
    Type: Grant
    Filed: August 8, 2013
    Date of Patent: April 22, 2014
    Assignee: The Regents of the University of California
    Inventors: John C. Jewett, Carolyn R. Bertozzi, Ellen May Sletten, Chelsea G. Gordon
  • COMPOSITIONS AND METHODS FOR MODIFICATION OF BIOMOLECULES
    Publication number: 20140045207
    Abstract: Provided are modified cycloalkyne compounds; and methods of use of such compounds in modifying biomolecules. Embodiments include a cycloaddition reaction that can be carried out under physiological conditions. The cycloaddition reaction involves reacting a modified cycloalkyne with an azide moiety on a target biomolecule, generating a covalently modified biomolecule. The selectivity of the reaction and its compatibility with aqueous environments provide for its application in vivo and in vitro.
    Type: Application
    Filed: August 8, 2013
    Publication date: February 13, 2014
    Applicant: The Regents of the University of California
    Inventors: John C. Jewett, Carolyn R. Bertozzi, Ellen May Sletten, Chelsea G. Gordon